Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma

Antibodies targeting the programmed cell death protein-1 (PD-1) molecule have been reported to hold promising antitumor activities in patients with nasopharyngeal carcinoma (NPC). However, only a small subset of NPC patients benefits from the anti-PD-1 monotherapy and factors that affect the treatme...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Liqin Xu, Yuxiang Ma, Chao Fang, Zhuobing Peng, Fangfang Gao, Janne Marie Moll, Shishang Qin, Qichao Yu, Yong Hou, Karsten Kristiansen, Wenfeng Fang, Susanne Brix, Li Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-08-01
coleção:	Frontiers in Oncology
Assuntos:	NPC immunotherapy PD-1 TMB HLA EBV
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.953884/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!